Invention Grant
US07906515B2 Cancer treatment with topoisomerase-II inhibitor, a bis-dioxypiperazine and radiation
有权
用拓扑异构酶II抑制剂，双二氧嘧啶和辐射进行癌症治疗
- Patent Title: Cancer treatment with topoisomerase-II inhibitor, a bis-dioxypiperazine and radiation
- Patent Title (中): 用拓扑异构酶II抑制剂，双二氧嘧啶和辐射进行癌症治疗
-
Application No.: US10591847Application Date: 2005-03-02
-
Publication No.: US07906515B2Publication Date: 2011-03-15
- Inventor: Kenneth Hofland , Maxwell Sehested , Paul Kristjansen , Annemette Thougaard , Peter Buhl Jensen
- Applicant: Kenneth Hofland , Maxwell Sehested , Paul Kristjansen , Annemette Thougaard , Peter Buhl Jensen
- Applicant Address: DK Copenhagen
- Assignee: Topotarget A/S
- Current Assignee: Topotarget A/S
- Current Assignee Address: DK Copenhagen
- Agency: Nixon & Vanderhye P.C.
- Priority: GB0404675.1 20040302
- International Application: PCT/IB2005/000670 WO 20050302
- International Announcement: WO2005/084754 WO 20050915
- Main IPC: A61K31/497
- IPC: A61K31/497 ; A61K31/357
Abstract:
The present invention relates to a method of treatment of a tumour cell which comprises administering to a subject in need of treatment an effective amount of a topoisomerase-II poison, e.g. etoposide, in combination with a bis-dioxypiperazine, e.g. dexrazoxane wherein said subject is further treated with radiation.
Public/Granted literature
- US20070185124A1 Cancer treatment with topoisomerase-ii inhibitor, a bis-dioxypiperazine and radiation Public/Granted day:2007-08-09
Information query
IPC分类:
